Abstract

The complement system (CS) is part of the human immune system, consisting of more than 30 proteins that play a vital role in the protection against various pathogens and diseases, including viral diseases. Activated via three pathways, the classical pathway (CP), the lectin pathway (LP), and the alternative pathway (AP), the complement system leads to the formation of a membrane attack complex (MAC) that disrupts the membrane of target cells, leading to cell lysis and death. Due to the increasing number of reports on its role in viral diseases, which may have implications for research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), this review aims to highlight significant progress in understanding and defining the role of the complement system in four groups of diseases of viral etiology: (1) respiratory diseases; (2) acute liver failure (ALF); (3) disseminated intravascular coagulation (DIC); and (4) vector-borne diseases (VBDs). Some of these diseases already present a serious global health problem, while others are a matter of concern and require the collaboration of relevant national services and scientists with the World Health Organization (WHO) to avoid their spread.

MeSH

Complement System Proteins, Virus Diseases, Membranes, Cells, Disseminated Intravascular Coagulation, Liver Failure, Acute, Vector Borne Diseases, Covid-19, Sars-Cov-2

Cited by

• Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients. Autoimmun Rev, 2022
• Complement C3 Facilitates Stratification of Stages of Chronic Hepatitis B and Signifies Development of Acute-on-Chronic Liver Failure in Acute Decompensated Cirrhosis. Adv Ther, 2023
• Complement-activated fragment Ba functions as an antibacterial protein and mediates immune responses in lower vertebrates. J Biol Chem, 2025
• Integrated multi-omics analysis reveals complement component 3 as a central driver of immune dysregulation in polycystic ovary syndrome. Front Endocrinol (Lausanne), 2025
• Association between trauma exposure and respiratory disease-A Mendelian randomization study. Front Endocrinol (Lausanne), 2022
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study. Clin Transl Sci, 2025
• Guardians of Immunity: Advances in Primary Immunodeficiency Disorders and Management. Cureus, 2023
• Hypoxic Stress Induces Complement-Mediated Lysis of Mesenchymal Stem Cells by Downregulating Factor H and CD59. Tissue Eng Regen Med, 2025
• Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies. J Immunother Cancer, 2023
• Human Complement Inhibits Myophages against . Viruses, 2023
• A bioinformatic analysis to systematically unveil shared pathways and molecular mechanisms underlying monkeypox and its predominant neurological manifestations. Front Cell Infect Microbiol, 2025
• Locally generated C3 regulates the clearance of by IFN-γ-primed macrophage through regulation of xenophagy. Front Microbiol, 2022